Study to Evaluate the Natural History of Head and Neck Cancer Precursors in Taiwan
Natural History Of Oral Cancer Precursor Lesions: A Prospective Cohort Study
2 other identifiers
observational
3,576
1 country
4
Brief Summary
Background: \- Cancer of the mouth and throat is one of the most common cancers in Taiwan. This cancer develops over several years, beginning as white or red patches in the mouth or throat that become growths. It can also cause a condition that leads to rigidity of the cheeks. The growths can be identified when a doctor looks into a person s mouth. It is currently not clear why some people with abnormal growths progress to cancer while others do not. Researchers want to better understand why some patients with early abnormal growths get late abnormal growths. They also want to understand why some people get abnormal growths again, even after they receive treatment. Objectives: \- To understand why some people with precancerous lesions in their mouth develop cancer while others do not. Eligibility: \- Adults 21 years and older, some with abnormal growths in the mouth, some without any, and some with head and neck cancer. Design:
- Participants will visit a hospital in Taiwan 2 times.
- At the first visit, participants will answer questions about their health, lifestyle, and family medical history. A doctor will examine the participant s mouth and take a small piece of any growth they see. They will do this with a brush. They will also photograph the participant s mouth. Participants will also give blood and saliva samples, plus a small sample of a mouth rinse.
- Participants who are diagnosed with a late abnormal growth that is not cancer will return for a second visit. They will answer the same questions and undergo the same procedures as at the first study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2013
Longer than P75 for all trials
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 18, 2013
CompletedFirst Submitted
Initial submission to the registry
December 19, 2013
CompletedFirst Posted
Study publicly available on registry
December 20, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 4, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
February 4, 2021
CompletedFebruary 8, 2021
February 1, 2021
7.2 years
December 19, 2013
February 4, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Progression to dysplasia/cancer in participants with oral precursors.
Histologically confirmed progression to dysplasia/cancer in participants with oral precursors.
Follow-up visits every 6 months for 5 years
Study Arms (3)
Cancer
Participants diagnosed with incident oral cancer
Control
Participants without oral lesions or cancers matched to oral cancer/precursor participants on age, gender, smoking/betel nut habits
Precursor
Participants clinically diagnosed with oral lesions
Eligibility Criteria
A prospective cohort study of 3000 patients with precursors to investigate the natural history of histologically-defined oral cancer precursor lesions and evaluate epidemiologic/ molecular predictors for progression. This prospective component will be complemented by cross-sectional comparisons of epidemiologic/molecular factors across 750 controls, 3000 precursors, and 750 cancers.
You may qualify if:
- We plan to recruit all patients (controls, precursors, and invasive cancers) at the aforementioned two hospitals. Doctors at these hospitals conduct routine visual and tactile examination as part of Taiwan s national oral cancer screening program. For this screening program, all individuals aged 21 years or older who chew betel-quid or smoke are screened through visual inspection for the presence of precursor lesions or cancer.
You may not qualify if:
- Participants younger than 21 years and individuals with a history of head and neck cancer will be excluded from the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- National Cancer Institute (NCI)lead
- National Taiwan Universitycollaborator
- Academia Sinica, Taiwancollaborator
- China Medical University, Chinacollaborator
Study Sites (4)
Chang Gung Memorial Hospital - Kaohsiung
Kaohsiung City, Taiwan
China Medical University Hospital
Taichung, 40402, Taiwan
National Taiwan University Hospital
Taipei, Taiwan
Chang Gung Memorial Hospital- Taoyuan
Taoyuan District, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anil K Chaturvedi, M.D.
National Cancer Institute (NCI)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 19, 2013
First Posted
December 20, 2013
Study Start
November 18, 2013
Primary Completion
February 4, 2021
Study Completion
February 4, 2021
Last Updated
February 8, 2021
Record last verified: 2021-02